🇺🇸 FDA
Patent

US 7364726

Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

granted A61KA61K2039/5152A61K2039/55522

Quick answer

US patent 7364726 (Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine) held by The Regents of the University of California expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K2039/5152, A61K2039/55522, A61K2039/55527, A61K2039/55533